{"id":"roxane-laboratories-inc-usa","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Insomnia"},{"rate":"5-10%","effect":"Anxiety"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by increasing the levels of dopamine and norepinephrine in the brain, which helps to improve focus and attention.","oneSentence":"Roxane Laboratories Inc., USA's drug is a central nervous system stimulant.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:32:54.403Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention deficit hyperactivity disorder"}]},"trialDetails":[{"nctId":"NCT02635438","phase":"PHASE3","title":"A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal Candidiasis.","status":"UNKNOWN","sponsor":"Thinq Pharma-CRO Pte. Ltd.","startDate":"2016-12","conditions":"Oropharyngeal Candidiasis","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Roxane Laboratories Inc., USA","genericName":"Roxane Laboratories Inc., USA","companyName":"Thinq Pharma-CRO Pte. Ltd.","companyId":"thinq-pharma-cro-pte-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Roxane Laboratories Inc. is a pharmaceutical company based in the USA that has developed a product, Clotrimazole Troche 10mg, for the treatment of Oropharyngeal Candidiasis. The company's product is a small molecule inhibitor of the hepatocyte growth factor receptor, which is a mechanism of action also associated with the drug Capmatinib.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}